1. Hem
  2. Products
  3. Elocta
  4. About haemophilia A
  5. Personalised protection
Se-Elocta-0

Personalised protection

Prophylaxis can help patients achieve increased protection against bleeds, resulting in improved joint health and a better quality of life.1

Because different activities require different FVIII levels to stay protected, it’s important to tailor treatment around each of your patient’s lifestyles and clinical needs.1,2

Different activities and clinical settings require different FVIII levels*2

Prophylaxis graph
Treatment graph

Adapted from Iorio A, et al. 2017.

*This consensus was established by the Delphi technique. In these areas, a consensus was not reached and the areas were identified and proposed for future research.
†Based on German treatment guidelines.

Prophylaxis should be personalised to your patients’ individual needs, taking into consideration their:1

• physical activity levels
• PK profile
• comorbidities
• age
• lifestyle and personal preferences

The World Federation of Haemophilia recommends that prophylaxis should:1
• be individualised, determined jointly with the patient and based on their lifestyle and personal preferences
• aim to enable people with haemophilia to lead active lives and achieve a quality of life comparable to those without haemophilia

Access the full World Federation of Haemophilia 2020 Guidelines here.

Personalised prophylaxis provides protection that can be adapted to each patient's individual needs.1,2

Personalise protection to different patients' needs with ELOCTA individualised prophylaxis.3

Find out more

FVIII, factor VIII; ICH, intracranial haemorrhage; PK, pharmacokinetic.

References

1. Srivastava A, et al. Haemophilia 2020;26(6):1–158. 2. Iorio A, et al. Haemophilia 2017;23(3):170–179 3. ELOCTA SmPC 01/2021.

PP-18595
Other sites
expand_less